sulbactam and durlobactam
A Targeted Treatment for Carbapenem-Resistant Acinetobacter baumannii
The approval of sulbactam-durlobactam for the treatment of carbapenem-resistant Acinetobacter baumannii infections ...
APRIL 1, 2025
FDA Approves Xacduro for HABP and VABP caused by Acinetobacter
Xacduro consists of sulbactam, a drug structurally related to penicillin, and durlobactam, which protects ...
MAY 24, 2023
Load more